UREA- urea cream 
AvKARE

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Urea Cream 40%

Rx Only

For external use only. Not for ophthalmic use.

Description

Urea 40% is a keratolytic emollient which is a gentle, yet potent, tissue softener for nails and/or skin. Each gram of Urea 40%contains 40% urea as an active ingredient, and the following inactive ingredients:

Carbomer, Cetearyl Alcohol, Glycerin,

Glyceryl Stearate SE, Mineral Oil, Purified Water,

White Petrolatum

Urea is a diamide of carbonic acid with the following chemical structure:

structure

Clinical Pharmacology

Urea gently dissolves the intracellular matrix which results in loosening of the horny layer of the skin and shedding of scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Pharmacokinetics

The mechanism of action of topically applied urea is not yet known.

Indications and Usage

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

Contraindications

Known hypersensitivity to any of the listed ingredients.

Warnings

For topical use only. Avoid contact with eyes, lips or mucous membranes.

Precautions

This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

PREGNANCY: Pregnancy Category B. Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, Urea 40% should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS: It is not known whether or not this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Urea 40% is administered to a nursing woman.

Adverse Reactions

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the medication.

To report SUSPECTED ADVERSE REACTIONS contact AvKARE, Inc. at 1-855-361-3993; email
drugsafety@avkare.com; or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Dosage and Administration

Apply Urea 40% to affected skin twice per day, or as directed by your physician. Rub in until completely absorbed.
Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

How Supplied

Urea 40% Cream

1 oz. (28.35 g):

Bottle NDC 42291-849-28

Tube NDC 42291-849-29


Urea 40% Cream

3 oz. (85 g): NDC 42291-849-85


Urea 40% Cream

7 oz. (198.4 g): NDC 42291-849-19


Store at room temperature 15°C - 30°C (59°F-86°F).

Protect from freezing. Keep bottle tightly closed.



KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.



Manufactured for:
AvKARE
Pulaski, TN 38478

AV 06/22

Tube Label

28.35

29

85

198.4

UREA 
urea cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42291-849
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W) UREA40 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
CETYL ALCOHOL (UNII: 936JST6JCN)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
XANTHAN GUM (UNII: TTV12P4NEE)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
PARAFFIN (UNII: I9O0E3H2ZE)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42291-849-281 in 1 CARTON11/06/201712/31/2023
128 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
2NDC:42291-849-851 in 1 CARTON11/06/2017
285 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
3NDC:42291-849-191 in 1 CARTON11/06/2017
3198 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
4NDC:42291-849-291 in 1 CARTON06/08/202206/13/2022
428 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/06/2017
Labeler - AvKARE (796560394)

Revised: 4/2024
Document Id: 1547fa22-281f-34ef-e063-6394a90aee62
Set id: 65f56eff-4f67-4cbf-a801-a632261afc29
Version: 13
Effective Time: 20240404
 
AvKARE